Old Web
English
Sign In
Acemap
>
authorDetail
>
Cassie Dong
Cassie Dong
Takeda Pharmaceutical Company
Rare disease
hodgkin lymphoma
Internal medicine
Young adult
young age
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Brentuximab vedotin with chemotherapy in adolescents and young adults (AYAs) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 Echelon-1 study.
2021
Journal of Clinical Oncology
Howland E. Crosswell
Ann S. LaCasce
Nancy L. Bartlett
David J. Straus
Kerry J. Savage
Pier Luigi Zinzani
Graham P. Collins
Michelle A. Fanale
Keenan Fenton
Cassie Dong
Harry H. Miao
Andrew Grigg
Show All
Source
Cite
Save
Citations (0)
BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN ADOLESCENTS AND YOUNG ADULTS (AYAS) WITH STAGE III OR IV HODGKIN LYMPHOMA: A SUBGROUP ANALYSIS FROM THE PHASE 3 ECHELON-1 STUDY
2021
Hematological Oncology
Howland E. Crosswell
Ann S. LaCasce
Nancy L. Bartlett
David J. Straus
Kerry J. Savage
Pier Luigi Zinzani
Graham P. Collins
Michelle A. Fanale
Keenan Fenton
Cassie Dong
Harry H. Miao
Andrew Grigg
Show All
Source
Cite
Save
Citations (0)
1